Tag: Dupilumab
Dupilumab maintains its effectiveness up to five years in patients with eczema: Study Medical Xpress Source link
Dupixent® (dupilumab) Late-Breaking Data at AAD Show Significant … GlobeNewswire Source link
New research shows baricitinib could be an effective treatment option for patients with atopic dermatitis who do not respond to dupilumab. A team, led by Linde de Wijs, Department of Dermatology, Erasmus MC University Medical Center, evaluated the effectiveness and safety of baricitinib treatment in daily practice for patients with atopic dermatitis who have inadequately responded […]
Dupilumab had an acceptable long-term safety and efficacy for adolescents with moderate to severe atopic dermatitis (AD), according to data from an open-label extension (OLE) phase 3 trial published in the American Journal of Clinical Dermatology. For adolescents (aged 12 to 18 years) with moderate to severe AD enrolled in the LIBERTY AD PED-OLE study, […]